Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone Use in Cystic Fibrosis
NCT00005112Phase 3Completed
- Sponsor
- National Center for Research Resources
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of somatropin in cystic fibrosis (CF) (2 arms), sponsored by National Center for Research Resources. Primary endpoints: Height at 24 months, Height velocity at 24 months and 3 more. Status: completed.
02
Drugs
somatropin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00005112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005112.